186 related articles for article (PubMed ID: 28452680)
1. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
[TBL] [Abstract][Full Text] [Related]
2. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of the fractionation of palliative radiotherapy for bone metastasis in Ontario.
Kong W; Zhang-Salomons J; Hanna TP; Mackillop WJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1209-17. PubMed ID: 17967310
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
[TBL] [Abstract][Full Text] [Related]
5. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
[TBL] [Abstract][Full Text] [Related]
6. Fractionation of Palliative Radiation Therapy for Bone Metastases in Ontario: Do Practice Guidelines Guide Practice?
Ashworth A; Kong W; Chow E; Mackillop WJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):31-39. PubMed ID: 26454681
[TBL] [Abstract][Full Text] [Related]
7. Palliative radiotherapy fractionation schedules prescribed are dependent on the distance a patient travels to receive treatment.
Barnes M; Tiwana MS; Miller S; Kiraly A; Olivotto IA; Emmons S; Olson RA
Radiother Oncol; 2015 Nov; 117(2):390-2. PubMed ID: 26522059
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care and survival outcomes of palliative radiation for prostate cancer with bone metastases: comparison of ≤5 fractions to ≥10 fractions.
Schreiber D; Safdieh J; Becker DJ; Schwartz D
Ann Palliat Med; 2017 Jan; 6(1):55-65. PubMed ID: 28209069
[TBL] [Abstract][Full Text] [Related]
9. [Radiosensitivity of bone metastases from tumors in different primary sites].
Khmelevsky EV; Bychkova NM
Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
[TBL] [Abstract][Full Text] [Related]
10. Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW; Baumann BC; Apicelli A; Rao YJ; Roach M; Daly M; Dans MC; White P; Contreras J; Henke L; Gay H; Michalski JM; Abraham C
Cancer Med; 2018 Sep; 7(9):4240-4250. PubMed ID: 30120817
[TBL] [Abstract][Full Text] [Related]
11. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
12. Palliative radiotherapy for women with breast cancer.
Danielson B; Winget M; Gao Z; Murray B; Pearcey R
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):506-12. PubMed ID: 18524556
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
14. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
15. [Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].
Khmelevskiĭ EV; Pan'shin GA; Dobrovol'skaia NIu; Bol'shakova SA
Vopr Onkol; 2012; 58(3):380-6. PubMed ID: 22888655
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbidity on survival after palliative radiotherapy.
Nieder C; Engljähringer K; Angelo K
Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for bone metastases: practice in Norway 1997-2007. A national registry-based study.
Laugsand TS; Kaasa S; Romundstad P; Johannesen TB; Lund JÅ
Acta Oncol; 2013 Aug; 52(6):1129-36. PubMed ID: 23244670
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation with local-field radiotherapy for painful bone metastases.
Hayashi S; Hoshi H; Iida T
Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
Nieder C; Kämpe TA
Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
